Arin戰術極端風險主動型ETF ATTR 深 滬
等待開盤 05-13 09:30:00 美东时间
93.9146
-0.045
-0.05%
華盛通- 最 高93.9146
- 今 開93.92
- 成交量 262股
- 最 低 93.9146
- 昨 收 93.96
- 總市值 9289.09万
- 52周最高 93.96
- 市盈率 靜 --
- 換手率 0.03%
- 52周最低 88.71
- 委 比 15.00%
- 總股本 98.91万
- 歷史最高 93.96
- 量 比 0
- 振 幅 0.00%
- 歷史最低 88.71
- 每 手 1
- 風險率 1.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BridgeBio falls despite new Attruby data
BridgeBio Pharma (BBIO) is down ~4% in Monday trading despite releasing phase 3 heart failure data for Attruby (acoramidis). Results from the ATTRibute-CM study found that the drug led to consistent a...
05-12 03:11
BridgeBio Pharma's Acoramidis Receives Marketing Authorization From Brazil's Health Regulatory Agency To Treat Transthyretin Amyloidosis
BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, today announced the Brazilian Health Regulatory Agency (ANVISA) has granted
05-06 19:42
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View
Pfizer beats Q1 estimates with revenue growth and strong pipeline progress, extends Vyndamax patent outlook, and backs 2026 guidance.
05-06 00:15
Intellia Therapeutics prices $180M stock offering at discount
Intellia Therapeutics (NTLA) on Wednesday said it priced an underwritten public offering of 16.74M shares at $10.75 each, for expected gross proceeds of about $180M. Shares down -11% in premarket. Th...
04-29 20:50
Pfizer Stock Is Declining Today: What's Happening?
Pfizer Inc. shares are dipping on Tuesday. The company announced settlement agreements extending the effective U.S. patent life of Vyndamax.
04-29 01:23
Prothena Announces Coramitug Amyloid Depleter Antibody Receives FDA's Fast Track Designation To Treat ATTR Amyloidosis With Cardiomyopathy
Prothena Corporation plc (NASDAQ:PRTA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to coramitug, a potential best-in-class amyloid depleter antibody currently in
04-28 04:12
BRIEF-TSMC: Demand Is Very Robust
BRIEF-TSMC: Demand Is Very Robust April 16 (Reuters) - Taiwan Semiconductor Manufacturing Co Ltd 2330.TW : TSMC: DEMAND IS VERY ROBUST TSMC: DEMAND CONTINUES TO INCREASE TSMC: CUSTOMERS GIVE POSITIVE OUTLOOK TSMC: WE HAVE TO SPEED UP BUILD UP OF CLEAN ROOMS, BUYING TOOLS TSMC: AI IS SO STRONG TSMC:
04-16 15:07
Iran war brings US close to net crude exporter for first time since World War Two
Iran war brings US close to net crude exporter for first time since World War Two Net imports of US crude narrows to lowest on record last week US exports climb to seven-month high on wide Brent-WTI spread US exports near capacity limits, analysts and traders say By Arathy Somasekhar and Georgina Mc
04-16 10:28
Alnylam Presents New Clinical, Real-World Data From Cardiovascular Portfolio At ACC.26, Reinforcing Potential Of RNAi To Deliver Fundamentally Differentiated, Effective, And Durable Impact For Patients Living With CVD
− Vutrisiran, which Silences Transthyretin at the Source, Shown to Improve Health-Related Quality-of-Life in Those with ATTR-CM, with Treatment Effects Comparable to Patients More than Ten Years Younger –− Findings
03-31 01:03
BRIEF-SMIC FY Net Income Attributable USD685.1 Million
BRIEF-SMIC FY Net Income Attributable USD685.1 Million March 26 (Reuters) - Semiconductor Manufacturing International Corp 0981.HK : FY NET INCOME ATTRIBUTABLE USD 685.1 MILLION FY REVENUE USD 9,327 MILLION IF EXPORT CONTROL MEASURES OF US, OTHERS AGAINST CHINA BECOME MORE STRINGENT IN FUTURE, CO MA
03-26 20:53
